Skip to main content

An Internet-based survey to evaluate the comfort and need for further pubovaginal sling training

Abstract

Introduction and hypothesis

The pubovaginal sling (PVS) dates to the 1940s as an efficacious surgical treatment for stress urinary incontinence (SUI). Recently, it has been replaced by the midurethral sling (MUS). Since 2008, international regulatory agencies increased regulation and issued warnings on vaginal mesh for repair of pelvic organ prolapse (POP), which has led to increased scrutiny of the MUS. Thus, the need for surgical comfort with PVS is resurfacing. We sought to evaluate the surgical practice patterns among international urogynecologists for the treatment of SUI and identify whether a need and interest for more training exists.

Methods

We developed a short, Internet-based survey for members of the International Urogynecological Association (IUGA). Descriptive analyses, binomial and multivariate logistic regressions were calculated to determine significant associations.

Results

Among 556 members who responded to the survey, 72% did not offer PVS in practice. Among those who did, there was as significant relationship between offering PVS and practicing in the United States, board-certification in urogynecology, PVS exposure in training, increasing number of PVS performed during training, and comfort with PVS. Members interested in further PVS training were younger, less comfortable with PVS, performed fewer PVS, or had no exposure in training.

Conclusion

Most IUGA members do not offer PVS in clinical practice. As would be expected, members who performed more PVS in training and were more comfortable with PVS were likely to offer it to patients. Our results highlight a learning gap, especially among younger providers who are not comfortable with PVS and desire further training in this procedure.

This is a preview of subscription content, access via your institution.

Fig. 1

Abbreviations

SUI:

Stress urinary incontinence

PVS:

Pubovaginal sling

MUS:

Midurethral sling

FDA:

Food and Drug Administration

TVT:

Tension-free vaginal tape

POP:

Pelvic organ prolapse

IUGA:

International Urogynecological Association

AUGS:

American Urogynecologic Society

US:

United States

UK:

United Kingdom

TGA:

Therapeutic Goods Administration

FPMRS:

Female Pelvic Medicine and Reconstructive Surgery

SUFU:

Society of Urodynamic and Female Pelvic Medicine and Urogenital Reconstruction

AUA:

American Urological Association

AGSA:

Urogynaecological Society of Australasia

References

  1. Kobashi KC, Albo ME, Dmochowski RR, et al. Surgical treatment of female stress urinary incontinence; AUA/SUFU guideline. J Urol. 2017;198:875–83.

    Article  PubMed  Google Scholar 

  2. McGuire EJ, Lytton B. Pubovaginal sling procedures for stress incontinence. J Urol. 1978;119:82–4.

    Article  CAS  PubMed  Google Scholar 

  3. Chaikin DC, Rosenthal J, Blaivas JG. Pubovaginal fascial slings for all types of stress urinary incontinence: long-term analysis. J Urol. 1998;160:1312–6.

    Article  CAS  PubMed  Google Scholar 

  4. Albo ME, Richter HE, Brubaker L, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med. 2007;356(21):2143–55.

    Article  CAS  PubMed  Google Scholar 

  5. Ford AA, Rogerson L, Cody JD, Ogah J. Mid-urethal sling operations for stress urinary incontinence in women (review). Cochr Database Syst Rev. 2015:7. https://doi.org/10.1002/14651858.CD006375.pub3.

  6. Ghoniem G, Hammett J. Female pelvic medicine and reconstructive practice patterns: IUGA member survey. Intl Urogynecol J. 2015;26:1489–94.

    Article  Google Scholar 

  7. Wadie Bs EA, Nabeeh AM. Autologous fascial sling vs polypropylene tape at short-term follow up: a prospective randomized study. J Urol. 2005;174:990–3.

    Article  PubMed  Google Scholar 

  8. FDA News Release. “Update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse: FDA safety communication.” July 12, 2011. Accessed January 2018. https://wayback.archive-it.org/7993/20170406003155, https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm.

  9. FDA News Release. “FDA strengthens requirements for surgical mesh for the transvaginal repair of pelvic organ prolapse to address safety risks.” January 4, 2016. Accessed January 2018. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm479732.htm.

  10. The Scientific Committee on Emerging and Newly Identified Health Risks. Opinion on the safety of surgical meshes used in urogynecological surgery. Accessed 2017. https://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_049.pdf.

  11. TGA Actions after review into urogynaecological surgical mesh implants. Accessed April 2018. https://www.tga.gov.au/alert/tga-actions-after-review-urogynaecological-surgical-mesh-implants

  12. Koski ME, Chamberlain J, Rosoff J, et al. Patient perception of transvaginal mesh and the media. Urology. 2014;84:575–82.

    Article  PubMed  Google Scholar 

  13. Rac G, Younger A, Clemens JQ, et al. Stress urinary incontinence surgery trends in academic female pelvic medicine and reconstructive surgery urology practice in the setting of the Food and Drug Administration pubic health notifications. Neuro Urody. 2017;36:1155–60.

    Article  CAS  Google Scholar 

  14. Brown J, King J. Age-stratified trends in 20 years of stress incontinence surgery in Australia. Austral N Z J Obstet Gynaecol. 2016;56:192–8.

    Article  Google Scholar 

  15. Clemons JL, Weinstein M, Guess M, et al. Impact of the 2011 FDA transvaginal mesh safety update on AUGS members’ use of synthetic mesh and biologic grafts in pelvic reconstructive surgery. Fem Pelv Med Recon Surg. 2013;19:191–8.

    Article  Google Scholar 

  16. Rehman H, Bezerra CCB, Bruschini H, Cody JD. Traditional suburethral sling operations for urinary incontinence in women (review). Cochr Database Syst Rev. 2011. https://doi.org/10.1002/14651858.CD001754.pub3.

  17. Kammerer-Doak D, Svabik K, Bazi T. Variability in practice patterns in stress urinary incontinence and pelvic organ prolapse: results of an IUGA survey. Int Urogynecol J. 2017;28:735–44.

    Article  PubMed  Google Scholar 

  18. Khaja A, Freeman RM. How often should shelf/Gellhorn pessaries be changed? A survey of IUGA Urogynaecologists. Int Urogynecol J. 2014;25:941–6.

    Article  CAS  PubMed  Google Scholar 

  19. FDA. Considerations about surgical mesh for SUI. Accessed 2018. https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/ucm345219.htm.

  20. AUGS. Position statement: mesh midurethral sling for stress urinary incontinence. Accessed 2018. https://www.augs.org/assets/1/6/AUGS-SUFU_MUS_Position_Statement.pdf.

  21. AUA. Position statement in the use of vaginal mesh for surgical treatment of stress urinary incontinence. Accessed 2018. http://www.auanet.org/guidelines/use-of-vaginal-mesh-for-the-surgical-treatment-of-stress-urinary-incontinence.

  22. UGSA Statement. Australian Senate Mesh Decision a Disservice to Women Accessed April 2018. http://www.ugsa.org.au/data/MESH/UGSA_response_to_senate_report.pdf.

  23. Mock S, Angelle J, Reynols WS, et al. Contemporary comparison between Retropubic Midurethral sling and autologous Pubovaginal sling for stress urinary incontinence after the FDA advisory notification. Urology. 2015;85:321–5.

    Article  PubMed  Google Scholar 

  24. Novara G, Artibani W, Barber MD, et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in surgical treatment of female stress urinary incontinence. Euro Urol. 2010;58:218–38.

    Article  Google Scholar 

  25. Blaivas JG, Sandhu J. Urethral reconstruction after erosion of slings in women. Curr Opin Urol. 2004;14:335–8.

    Article  PubMed  Google Scholar 

  26. Wu JM, Gandhi MP, Shah AD, et al. Trends in inpatient urinary incontinence surgery in the USA, 1998–2007. Intl Urogynecol J. 2011;22:1437–43.

    Article  Google Scholar 

  27. Oliphant SS, Wang L, Bunker CH, et al. Trends in stress urinary incontinence inpatient procedures in the United States, 1979-2004. Am J Obstet Gynecol. 2009;200:521.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Steele SS. Is there still a role for pubovaginal slings in the treatment of SUI in the era of mid-urethral slings? Can Urol Assoc J. 2012;6:41.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Ghoniem GM, Rizk DEE. Renaissance of the autologous pubovaginal sling. Int Urogynecol J. 2018;29:177–8.

    Article  PubMed  Google Scholar 

Download references

Funding source

Division of Urogynecology, Department of Obstetrics and Gynecology at University of California, Irvine.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Neha T. Sudol.

Ethics declarations

Conflicts of interest

None.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sudol, N.T., Dutta, S. & Lane, F. An Internet-based survey to evaluate the comfort and need for further pubovaginal sling training. Int Urogynecol J 30, 1173–1178 (2019). https://doi.org/10.1007/s00192-018-3695-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-018-3695-2

Keywords

  • Pubovaginal sling
  • Autologous fascia sling
  • Stress urinary incontinence
  • Midurethral sling
  • FDA warning